BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 24265197)

  • 1. Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy.
    Miao P; Sheng S; Sun X; Liu J; Huang G
    IUBMB Life; 2013 Nov; 65(11):904-10. PubMed ID: 24265197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.
    Granchi C; Roy S; Giacomelli C; Macchia M; Tuccinardi T; Martinelli A; Lanza M; Betti L; Giannaccini G; Lucacchini A; Funel N; León LG; Giovannetti E; Peters GJ; Palchaudhuri R; Calvaresi EC; Hergenrother PJ; Minutolo F
    J Med Chem; 2011 Mar; 54(6):1599-612. PubMed ID: 21332213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.
    Feron O
    Radiother Oncol; 2009 Sep; 92(3):329-33. PubMed ID: 19604589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
    Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M
    J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy.
    Koukourakis MI; Giatromanolaki A
    Int J Radiat Biol; 2019 Apr; 95(4):408-426. PubMed ID: 29913092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma.
    Li J; Zhu S; Tong J; Hao H; Yang J; Liu Z; Wang Y
    Neuroreport; 2016 Jan; 27(2):110-5. PubMed ID: 26694942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer.
    Augoff K; Hryniewicz-Jankowska A; Tabola R
    Cancer Lett; 2015 Mar; 358(1):1-7. PubMed ID: 25528630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms.
    Kolappan S; Shen DL; Mosi R; Sun J; McEachern EJ; Vocadlo DJ; Craig L
    Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):185-95. PubMed ID: 25664730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Biochemical and Clinical Perspectives of Lactate Dehydrogenase: An Enzyme of Active Metabolism.
    Khan AA; Allemailem KS; Alhumaydhi FA; Gowder SJT; Rahmani AH
    Endocr Metab Immune Disord Drug Targets; 2020; 20(6):855-868. PubMed ID: 31886754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics.
    Sharma D; Singh M; Rani R
    Semin Cancer Biol; 2022 Dec; 87():184-195. PubMed ID: 36371026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
    Ooi AT; Gomperts BN
    Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate, not pyruvate, is neuronal aerobic glycolysis end product: an in vitro electrophysiological study.
    Schurr A; Payne RS
    Neuroscience; 2007 Jul; 147(3):613-9. PubMed ID: 17560727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate shuttle: from substance exchange to regulatory mechanism.
    Wang X; Liu H; Ni Y; Shen P; Han X
    Hum Cell; 2022 Jan; 35(1):1-14. PubMed ID: 34606041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.
    Fantin VR; St-Pierre J; Leder P
    Cancer Cell; 2006 Jun; 9(6):425-34. PubMed ID: 16766262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy.
    Feng Y; Xiong Y; Qiao T; Li X; Jia L; Han Y
    Cancer Med; 2018 Dec; 7(12):6124-6136. PubMed ID: 30403008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate and malignant tumors: a therapeutic target at the end stage of glycolysis.
    Mathupala SP; Colen CB; Parajuli P; Sloan AE
    J Bioenerg Biomembr; 2007 Feb; 39(1):73-7. PubMed ID: 17354062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration.
    Caneba CA; Bellance N; Yang L; Pabst L; Nagrath D
    Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1036-52. PubMed ID: 22895781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials.
    Granchi C; Bertini S; Macchia M; Minutolo F
    Curr Med Chem; 2010; 17(7):672-97. PubMed ID: 20088761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unappreciated Role of LDHA and LDHB to Control Apoptosis and Autophagy in Tumor Cells.
    Urbańska K; Orzechowski A
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative metabolism in cancer growth.
    Ristow M
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):339-45. PubMed ID: 16778561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.